Weight regain after stopping semaglutide: the data and the 5-year cost math
Two-thirds of weight lost returns within a year of stopping. Here's the STEP 1 extension data, the decade-level cost of staying on treatment, and why the plan you pick at month one matters.
STEP 1 extension: what happens when you stop
The STEP 1 extension followed 327 participants for a year after the 68-week trial ended. On treatment, mean loss was 17.3%. A year after stopping, participants had regained 11.6 percentage points — a net loss of just 5.6% from baseline. Blood pressure, lipids, and other cardiometabolic gains reverted toward baseline as well. The message is not that semaglutide fails; it's that its benefits are present while you take it and largely reverse when you stop.
The maintenance economics
Chronic treatment has chronic costs. The question isn't whether you spend $145/month for one year — it's whether you spend it for five or ten. Flat-rate at $145/month totals $8,700 over five years and $17,400 over ten. A membership model at ~$230 all-in totals $13,800 and $27,600. Brand retail totals roughly $81,000 and $162,000. This is the frame that makes the pricing model you choose at month one consequential for the long run.
Options for long-term management
The literature points toward GLP-1 therapy as long-term treatment for most patients who respond — similar to how blood-pressure or cholesterol medicines are managed. That reframes cost: you're evaluating a maintenance medication, possibly for years. Options to discuss with a prescriber include maintenance dosing, structured lifestyle support, and periodic reassessment of benefit versus cost. None are reasons to stop without guidance — they're conversation starters.
The decision framework: price the decade
The most useful reframe in semaglutide purchasing is to think in years. A $145/month flat plan that doesn't add fees saves roughly $1,000/year versus a typical membership model — $5,000 over five years, $10,000 over ten. That difference buys a lot of flexibility. It's why our rubric weights pricing predictability, and why NexLife's flat-rate model earns its score. Whether treatment should continue is always a clinical decision.
What "maintenance" really means, and how to budget for it
The regain data reframe semaglutide from a course of treatment into an ongoing therapy, and that reframing has direct budgeting consequences most first-time buyers underestimate. If the realistic plan is multi-year use, then the relevant number was never the introductory monthly price — it's the fully-loaded cost at your maintenance dose, multiplied out across the years you expect to stay on it, adjusted for the real probability that you'll pause, switch, or stop at some point.
This is where pricing structure stops being a footnote and becomes the main event. A flat-rate plan that holds steady at your maintenance dose is not just cheaper on paper; it's predictable, which matters enormously for a purchase you'll repeat 60 or 120 times. A membership model that looked competitive at signup quietly compounds its recurring fee across every one of those months. A dose-tiered plan reaches its most expensive tier exactly when you reach maintenance — the phase you'll spend the most time in. Building a personal budget means picking a realistic time horizon (say, two or three years), pricing the maintenance dose under each model, and stress-testing the refund and pause terms for the likely event that life interrupts the plan. Our cost calculator handles the arithmetic; the discipline it enforces is thinking in years rather than months. Whether to continue treatment at all remains a clinical decision — but if you do continue, the pricing model you chose at the start will have quietly determined thousands of dollars of the outcome.
Frequently asked questions
How much weight do you regain after stopping semaglutide?
In the STEP 1 extension, patients regained about two-thirds of lost weight within a year of stopping — going from ~17.3% loss on treatment to ~5.6% net. Cardiometabolic improvements also reverted toward baseline.
Is semaglutide a lifetime medication?
For most patients who respond, the clinical framing is increasingly similar to other chronic-disease medications: the benefit is present while taking it and largely reverses when you stop. Duration and management are clinical decisions for your prescriber.
How much does long-term semaglutide cost over 5 years?
At July 2026 prices: flat-rate ($145/mo) totals ~$8,700 over five years; a membership model (~$230/mo) totals ~$13,800; brand retail totals ~$81,000. These assume stable advertised prices, which change.
Why does the pricing model matter so much for semaglutide?
Because semaglutide is typically long-term therapy, small monthly differences compound. A flat-rate plan versus a membership model can differ by ~$1,000/year — $10,000 over a decade — which is why the plan you choose at the start matters for years.
References
- Wilding JPH, et al. Weight regain after withdrawal of semaglutide (STEP 1 extension). Diabetes Obes Metab. 2022.
- Garvey WT, et al. STEP 5 two-year data. Nat Med. 2022.
- Semaglutide Price Guide July 2026 price report and trends page.
- Novo Nordisk. Wegovy Prescribing Information.
Clinical figures from published trials and FDA labeling; pricing from provider-advertised rates checked July 2026 and subject to change. Educational, not medical or financial advice.